Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05977049

Psychosocial Support for Patients With Takotsubo Syndrome

Led by Weill Medical College of Cornell University · Updated on 2025-07-28

24

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Takotsubo cardiomyopathy, also known as Takotsubo syndrome or "broken heart syndrome," causes symptoms similar to a heart attack, such as chest pain and shortness of breath. It mainly affects older women and can be triggered by emotional or physical stress. While the heart usually returns to normal shape within a month, many patients continue to experience cardiac and psychological symptoms, including anxiety, which may last long after the initial episode. There is currently no specialized intervention for Takotsubo Syndrome patients after diagnosis at Weill Cornell Medical Center. This study evaluates a virtual Takotsubo support group that offers psychosocial support through group therapy and education sessions held every other week for about 1 to 1.5 hours. The frequency and length of these sessions may be adjusted to meet participants' needs. The group will discuss strategies for preventing coronary artery disease and provide ongoing support for managing symptoms. Participants will join virtual group meetings and complete assessments measuring anxiety, depression, and quality of life at the start of the study and after one year. Researchers will track changes in anxiety using the State-Trait Anxiety Inventory (STAI) as the primary outcome, with depression and quality of life as secondary outcomes. The study aims to determine if participation in the support group reduces anxiety over the course of one year.

CONDITIONS

Brief Title

Psychosocial Support for Patients With Takotsubo Syndrome

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with a documented diagnosis of Takotsubo Syndrome
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Patients already undergoing psychotherapy for Takotsubo Syndrome or those who choose not to participate
  • Prisoners
  • Non-English speaking individuals
  • Pregnant women
  • Individuals unable to provide written informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or virtual)

Outpatient Treatment

Duration - Up to 1 year

Participants attend virtual group therapy and education sessions designed to provide psychosocial support for Takotsubo Syndrome.

Virtual group sessions once every other week for 1 to 1.5 hours on average

Trial Site Locations

Total: 1 location

1

Weill Cornell Medicine

New York, New York, United States, 10021

Actively Recruiting

Loading map...

Research Team

H

Heather Glum, BSN, MPA

D

Dolores Reynolds, BSN

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Prospective Observational Study of Myocardial Stunning in Pa...

Chronic Obstructive Pulmonary Disease

Actively Recruiting

1 location

Characterization of Acute Myocardial Damage With Spectral Co...

Myocarditis; Acute or Subacute

Actively Recruiting

1 location

Characterization of Primary and Secondary Stress-Related Tak...

Takotsubo Cardiomyopathy

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

Jelena-Rima Ghadri, Ilan Shor Wittstein, Abhiram Prasad...

https://pubmed.ncbi.nlm.nih.gov/29850871